First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
Clinical trial NCT05438329 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05438329
- Sponsor
- DualityBio Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-19
- Primary completion
- 2027-08-13
- Enrollment
- 1123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.